<DOC>
	<DOCNO>NCT03081039</DOCNO>
	<brief_summary>Compare efficacy adjuvant chemotherapy Cisplatin Carboplatin Gemcitabine versus Gemcitabine patient resect ablated intra-hepatic cholangiocarcinoma .</brief_summary>
	<brief_title>A Study Cisplatin Carboplatin With Gemcitabine Versus Gemcitabine Alone Adjuvant Therapy Patients With Resected Ablation Intra-Hepatic Cholangiocarcinoma</brief_title>
	<detailed_description>Phase III , multicenter , open label , randomize study Cisplatin Carboplatin Gemcitabine versus Gemcitabine alone adjuvant therapy patient resect ablated intra-hepatic cholangiocarcinoma . Subjects randomize 1:1 fashion Cisplatin Carboplatin Gemcitabine versus Gemcitabine alone .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>At least 18 year age , race sex eligible sign write consent undergone prior resection histological evidence intrahepatic cholangiocarcinoma Hematologic function : ANC ≥ 1.5 x 10 /L , platelet ≥ 75 x 10 /L , hemoglobin &gt; 9 g/dL Adequate liver function measure : total bilirubin ≤ 2.0 mg/dl , AST ALT ≤ 5 ULN , albumin ≥ 2.5 g/dl Adequate renal function measure : creatinine ≤ 2.9 mg/dl , &gt; 50 ml/min calculate CG equation Nonpregnant woman child bear potential fertile men require use effective contraception ( negative pregnancy test woman childbearing age ) ECOG status ≤ 1 screen Subjects eligible study meet inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>cholangiocarcinoma</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>carboplatin</keyword>
	<keyword>cisplatin</keyword>
</DOC>